Presentation ACC 2025 Outcomes after FFR-Guided PCI vs. CABG: Final 5-Year Follow-up of the FAME 3 Trial Presenter: William Fearon March 30, 2025 REGISTER for free or LOG IN to view this content Coronary Imaging & Physiology FFR Presentation ACC 2025 Up Next Presentation ACC 2025 STRIDE - Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes Presenter: Marc P. Bonaca March 29, 2025 More slides + Presentation ACC 2025 The MIGHTy-Heart Randomized Clinical Trial Presenter: Ruth Masterson Creber March 30, 2025 We Recommend
Presentation ACC 2025 STRIDE - Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes Presenter: Marc P. Bonaca March 29, 2025
Presentation ACC 2025 The MIGHTy-Heart Randomized Clinical Trial Presenter: Ruth Masterson Creber March 30, 2025